Lars Erik Bryld

Lars Erik Bryld

Clinical Associate Professor

Member of:

  • Dermatovenerology


Publication year:
All
1 - 10 out of 22Page size: 10
  1. 2024
  2. Published

    Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study

    Bertelsen, T., Egeberg, Alexander, Skov, Lone, Rasmussen, M., Bryld, Lars Erik, Funding, A., Ajgeiy, K. & Thein, D., 2024, In: Journal of the European Academy of Dermatology and Venereology. 38, 2, p. 332-339 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2023
  4. Published

    Drug survival of adalimumab, secukinumab, and ustekinumab in psoriasis as determined by either dose escalation or drug discontinuation during the first 3 years of treatment - a nationwide cohort study

    Thein, D., Rosenø, N. A. L., Maul, J., Wu, J. J., Skov, Lone, Bryld, Lars Erik, Rasmussen, M. K., Ajgeiy, K. K., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of Investigative Dermatology. 143, 11, 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study

    Loft, N., Egeberg, Alexander, Isufi, D., Rasmussen, M. K., Bryld, Lars Erik, Dam, T. N., Ajgeiy, K. K., Bertelsen, T. & Skov, Lone, 2023, In: Acta Dermato-Venereologica. 103, 7 p., adv12616.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study

    Nielsen, M., Thein, D., Rasmussen, M. K., Bertelsen, T., Dam, T. N., Skov, Lone, Bryld, Lars Erik, Wu, J. J., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of the American Academy of Dermatology. 88, 6, p. 1378-1381 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  7. 2022
  8. Published

    Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

    Egeberg, Alexander, Rosenø, N. A. L., Aagaard, D., Lørup, E. H., Nielsen, M., Nymand, L., Kristensen, L. E., Thyssen, Jacob Pontoppidan, Thomsen, Simon Francis, Cordtz, R. L., Loft, N., Skov, Lone, Bryld, Lars Erik, Rasmussen, M. K., Højgaard, P., Kristensen, S. & Dreyer, L., 2022, In: Seminars in Arthritis and Rheumatism. 53, 151979.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study

    Loft, N., Egeberg, Alexander, Rasmussen, M. K., Bryld, Lars Erik, Nissen, Christoffer Valdemar S, Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 8, p. 1284-1291 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2021
  11. Published

    Outcomes following a Mandatory Nonmedical Switch from Adalimumab Originator to Adalimumab Biosimilars in Patients with Psoriasis

    Loft, N., Egeberg, Alexander, Rasmussen, M. K., Bryld, Lars Erik, Nissen, Christoffer Valdemar S, Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2021, In: JAMA Dermatology. 157, 6, p. 676-683

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Reply to: “Comment on ‘Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'”

    Egeberg, Alexander, Bryld, Lars Erik & Skov, Lone, 2021, In: Journal of the American Academy of Dermatology. 85, 6, p. e379

    Research output: Contribution to journal › Letter › Research › peer-review

  13. Published

    Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study

    Loft, N., Egeberg, A., Rasmussen, M. K., Bryld, Lars Erik, Nissen, C. V., Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2021, In: Acta Dermato-Venereologica. 101, 1, p. 1-7 7 p., adv00357.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 2020
  15. Published

    Long-term evaluation of climatotherapy for psoriasis

    Trøstrup, H., Riis, P. T., Heidenheim, M., Bryld, Lars Erik & Jemec, Gregor, 2020, In: Dermatologic Therapy. 33, 3, 6 p., e13432.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 32369880